ACT001 modulates the NF-κB/MnSOD/ROS axis by targeting IKKβ to inhibit glioblastoma cell growth-Reference-Cited by-同舟云学术

ACT001 modulates the NF-κB/MnSOD/ROS axis by targeting IKKβ to inhibit glioblastoma cell growth

Published:2020-01-04 Issue:2 Volume:98 Page:263-277
ISSN:0946-2716
Container-title:Journal of Molecular Medicine
language:en
Short-container-title:J Mol Med

Author:

Li Qiuying,Sun Yu,Liu Bowen,Li Jiabo,Hao Xin,Ge Weizhi,Zhang Xuemei,Bao Shiqi,Gong Jianmiao,Jiang Zhenhuan,Qiu Chuanjiang,Zhao Liqing,Zhao Yapu,Chen Yue,Yang Xuejun,Ding Yahui,Wu Zhenzhou

Funder

the National Natural Science Foundation of China

National Natural Science Foundation of China

Natural Science Foundation of Tianjin City

the Natural Science Foundation of Tianjin

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Drug Discovery,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00109-019-01839-0.pdf

Reference50 articles.

1. Weller M, Wick W, Aldape K, Brada M, Berger M, Pfister SM et al (2015) Glioma. Nature reviews Disease primers 1:15017

2. Chinot OL, Wick W, Mason W, Henriksson R, Saran F, Nishikawa R, Carpentier AF, Hoang-Xuan K, Kavan P, Cernea D, Brandes AA, Hilton M, Abrey L, Cloughesy T (2014) Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. N Engl J Med 370:709–722

3. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO, European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups, National Cancer Institute of Canada Clinical Trials Group (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459–466

4. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996

5. Mehta M, Wen P, Nishikawa R, Reardon D, Peters K (2017) Critical review of the addition of tumor treating fields (TTFields) to the existing standard of care for newly diagnosed glioblastoma patients. Crit Rev Oncol Hematol 111:60–65

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure-activity relationship study of Pseudellone C as anti-glioma agents by targeting TNF/TNFR signaling pathway;European Journal of Medicinal Chemistry;2024-11

2. MCL restrained ROS/AKT/ASAH1 pathway to therapy tamoxifen resistance breast cancer by stabilizing NRF2;Cell Proliferation;2024-06-26

3. Alleviative effects of the parthenolide derivative ACT001 on insulin resistance induced by sodium propionate combined with a high-fat diet and its potential mechanisms;European Journal of Pharmacology;2024-05

4. Qing-Re-Yi-Liu decoction suppresses the malignant behaviors of breast cancer cells by attenuating the MnSOD/CaMKII/AMPK signaling and Warburg effect;2024-04-15

5. Pharmacological potential of micheliolide: A focus on anti-inflammatory and anticancer activities;Heliyon;2024-03